Cargando…

Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer

BACKGROUND: Gastric cancer (GC), an extremely aggressive tumor with a very different prognosis, is the third leading cause of cancer-related mortality. We aimed to construct a ferroptosis-related prognostic model that can be distinguished prognostically. METHODS: The gene expression and the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaotao, Yan, Qiaofeng, Xie, Linling, Xu, Shijie, Jiang, Kailin, Huang, Jiahua, Wen, Yi, Yan, Yanhua, Zheng, Junhui, Tang, Shuting, Nie, Kechao, Zheng, Zhihua, Pan, Jinglin, Liu, Peng, Huang, Yuancheng, Yan, Xingrui, Zou, Yushan, Chen, Xuan, Liu, Fengbin, Li, Peiwu, Zhuang, Kunhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937463/
https://www.ncbi.nlm.nih.gov/pubmed/33727924
http://dx.doi.org/10.1155/2021/6635526
Descripción
Sumario:BACKGROUND: Gastric cancer (GC), an extremely aggressive tumor with a very different prognosis, is the third leading cause of cancer-related mortality. We aimed to construct a ferroptosis-related prognostic model that can be distinguished prognostically. METHODS: The gene expression and the clinical data of GC patients were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus database (GEO). The ferroptosis-related genes were obtained from the FerrDb. Using the “limma” R package and univariate Cox analysis, ferroptosis-related genes with differential expression and prognostic value were identified in the TCGA cohort. Last absolute shrinkage and selection operator (LASSO) Cox regression was applied to shrink ferroptosis-related predictors and construct a prognostic model. Functional enrichment, ESTIMATE algorithm, and single-sample gene set enrichment analysis (ssGSEA) were applied for exploring the potential mechanism. GC patients from the GEO cohort were used for validation. RESULTS: An 8-gene prognostic model was constructed and stratified GC patients from TCGA and meta-GEO cohort into high-risk groups or low-risk groups. GC patients in high-risk groups have significantly poorer OS compared with those in low-risk groups. The risk score was identified as an independent predictor for OS. Functional analysis revealed that the risk score was mainly associated with the biological function of extracellular matrix (ECM) organization and tumor immunity. CONCLUSION: In conclusion, the ferroptosis-related model can be utilized for the clinical prognostic prediction in GC.